(Press-News.org) MINNEAPOLIS –Stroke treatments and prevention to improve quality of life for people who experience a stroke is poorer than researchers hoped, with stroke still taking nearly three out of five quality years off a person's life, according to a new study published in the October 9, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers say the findings leave considerable room for improvement in stroke treatment.
Stroke is the leading cause of adult disability and the fourth-leading cause of death in the United States.
"These results highlight the severe toll that stroke takes on millions of people every year," said study author Peter M. Rothwell, FMedSci, a professor with the John Radcliffe Hospital in Oxford, United Kingdom. "This is the first study since the 1990s to look at long-term quality of life after stroke and transient ischemic attack (TIA)."
For the study, 748 people who experienced stroke and 440 who had a TIA were followed for five years and given questionnaires that measured quality of life and utility, which places a numerical value on the desirability of various health outcomes. These values, which were based on responses from members of the general public, range from "worse than death" to "perfect health." Participants were compared to an age-matched control group. These types of measures are increasingly used to determine the cost-effectiveness of new treatments.
The study determined the five-year quality-adjusted life years for the participants, calculated by multiplying the time spent in a health state by the value assigned to that particular health state. For example, the study found that out of a possible five years of perfect health, people who had a stroke lost 1.71 years due to earlier death and another 1.08 years due to a reduced quality of life, resulting in a reduction of 2.79 quality-adjusted life years. The results varied greatly depending on severity of the stroke, with those having a minor stroke experiencing 2.06 fewer quality-adjusted life years; moderate, 3.35 years; and severe, 4.3 quality years. People who had TIAs had 1.68 fewer quality-adjusted life years.
"Our study should serve as a wake-up call that we need more funding and research for stroke treatments and secondary stroke prevention measures to improve quality of life in stroke survivors," said Rothwell.
INFORMATION:
The study was supported by the Economic and Social Research Council/Medical Research Council/National Institute for Health Research (NIHR), the NIHR Oxford Biomedical Research Centre Programme, the UK Medical Research Council, the Dunhill Medical Trust, Wellcome Trust and the UK Stroke Association.
To learn more about stroke, please visit http://www.aan.com/patients. To donate to brain research, please visit http://www.americanbrainfoundation.org.
The American Academy of Neurology, an association of more than 26,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson's disease and epilepsy.
For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.
Media Contacts:
Rachel Seroka, rseroka@aan.com, (612) 928-6129
Michelle Uher, muher@aan.com, (612) 928-6120
END
BOSTON (Wednesday, October 9, 2013, 5:00 pm ET) — Researchers from Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences have identified a possible topical treatment for age-related macular degeneration (AMD) in a study of mice that shows promise for clinical use. The research findings, published today in PLOS ONE, are the first to report successful topical use of a compound capable of inhibiting symptoms associated with both dry AMD (the earlier form) and wet AMD (the rarer, later form) and could represent a breakthrough for treatment ...
Forest cover around the world will continue a slow shrinking before stabilizing at a lower level, according to a new study from the University of Guelph.
Researchers analyzed forest trends from around the world and developed a mathematical model to show future land use changes. They found the most likely model shows forests will decline from 30 per cent of Earth's land mass today to 22 per cent within the next two centuries.
The model discusses different scenarios, such as global forest growth reversing deforestation, or reforestation cut short by renewed losses. ...
A panel of 15 medical experts from the fields of radiology, obstetrics-gynecology and emergency medicine, convened by the Society of Radiologists in Ultrasound (SRU), has recommended new criteria for use of ultrasonography in determining when a first trimester pregnancy is nonviable (has no chance of progressing and resulting in a live-born baby). These new diagnostic thresholds, published Oct. 10 in the New England Journal of Medicine, would help to avoid the possibility of physicians causing inadvertent harm to a potentially normal pregnancy.
"When a doctor tells a ...
An individual’s race or ethnic background could be a determining factor when it comes to risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UC San Francisco.
In a study to be published online October 8 and in the November 12 issue of Circulation, researchers discovered that self-described non-Hispanic whites are more likely to develop atrial fibrillation than people from other race or ethnic groups.
“We found that consistently, every other race had a statistically significant lower risk of atrial ...
A research team, headed by Theodore Friedmann, MD, professor of pediatrics at the University of California, San Diego School of Medicine, says a gene mutation that causes a rare but devastating neurological disorder known as Lesch-Nyhan syndrome appears to offer clues to the developmental and neuronal defects found in other, diverse neurological disorders like Alzheimer's, Parkinson's and Huntington's diseases.
The findings, published in the October 9, 2013 issue of the journal PLOS ONE, provide the first experimental picture of how gene expression errors impair the ...
Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by adding a second drug to the diabetes drug rosiglitazone, adverse events dropped enormously. That suggests that drugs could be repurposed to improve drug safety, including lowering the risk of heart attacks.
The research is published online Oct. 9 in the journal Science Translational Medicine.
The approach is part of an emerging strategy ...
ANN ARBOR, Mich. – Video ratings data of surgeons' operating skills successfully predicted whether patients would suffer complications after they leave the operating room, according to a University of Michigan Health System study.
The study assessed the relationship between the technical skill of 20 bariatric surgeons and post-surgery complications in 10,343 patients undergoing common, but complex laparoscopic gastric bypass surgery.
High skill surgeons, as rated by their peers, had significantly fewer post-surgery complications such as bleeding or infections, according ...
Some breast cancer drugs can penetrate the blood-brain barrier (BBB), but they have not been very effective against brain metastases, whereas other, more effective anti-breast cancer drugs cannot penetrate the BBB at all. In a study published October 9 in the Journal of the National Cancer Institute, researchers used a new approach to selectively permeabilize the BBB at sites of brain metastases, even those 200 times smaller than currently detectable in the clinic.
To facilitate drug delivery to brain metastases, John Connell of the CRUK/MRC Gray Institute for Radiation ...
LA JOLLA, CA—October 9, 2013—Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.
One of the newly identified compounds, a Parkinson's disease drug called benztropine, was highly effective in treating a standard model of MS in mice, both alone and in combination with existing MS therapies.
"We're excited about ...
Ecological and societal disruptions by modern climate change are critically determined by the time frame over which climates shift. Camilo Mora and colleagues in the College of Social Sciences' Department of Geography at the University of Hawaii, Manoa have developed one such time frame. The study, entitled "The projected timing of climate departure from recent variability," will be published in the October 10 issue of Nature and provides an index of the year when the mean climate of any given location on Earth will shift continuously outside the most extreme records experienced ...
